Malaysia cardiovascular
devices market is anticipated to witness a growth of steady CAGR in the
forecast period, 2024-2028. The cardiovascular devices market in Malaysia has
witnessed significant growth over the past few years, owing to the increasing
adoption of sedentary lifestyles and unhealthy diets in the country.
Cardiovascular diseases (CVDs) continue to be a major health concern in
Malaysia, with a significant number of people affected each year. It has
been reported that cardiovascular disease cases increase by 5% every
year in Malaysia. Sedentary lifestyles refer to a lack of physical
activity, which can be a result of a variety of factors such as long working
hours, increased use of technology, and the availability of modern
conveniences. In Malaysia, many people lead sedentary lifestyles due to long
commutes, desk-bound jobs, and a lack of access to recreational facilities.
This lack of physical activity can lead to a variety of health problems,
including obesity (according to the National Health and Morbidity Survey
(NHMS) 2019, Malaysia’s obesity rate amongst 18 years and above is reported to
be 19.7%), hypertension (approximately 30% of Malaysians aged 18 years
and above are affected from hypertension, according to the Malaysian National
Health and Morbidity Survey 2019), and diabetes (the diabetes prevalence
in Malaysia ranges from 7.3% to 23.8%, according to published reports),
which are all risk factors for CVDs.
In addition to
sedentary lifestyles, unhealthy diets are also contributing to the rising
incidence of CVDs in Malaysia. The traditional Malaysian diet is high in fat,
sugar, and salt, and lacks enough fruits, vegetables, and whole grains. The
consumption of processed foods and sugary drinks has also increased in recent
years, contributing to the growing problem of obesity and related health
issues. The combination of sedentary lifestyles and unhealthy diets is a major
risk factor for CVDs. People who lead sedentary lifestyles are more likely to
develop high blood pressure, high cholesterol, and other risk factors for CVDs.
Similarly, those who consume a diet high in fat, sugar, and salt are more
likely to develop obesity, diabetes, and other health problems that increase
the risk of CVDs.
Moreover, a rise
in geriatric population in the nation is another contributing
factor to the rise of Malaysia cardiovascular devices market. According to
the United Nations Population Fund (UNFPA), the elderly population in Malaysia,
aged 60 years and above, will increase from 3.2 million in 2020 to 5.3 million
by 2030.
Increasing Prevalence of Cardiovascular Diseases in Malaysia
Cardiovascular diseases (CVDs) are one of the leading causes of death in
Malaysia, with an estimated 40% of all deaths in the country attributed to
CVDs. The prevalence of CVDs in Malaysia has been
steadily increasing in recent years, which is a cause for concern for the
healthcare system in the country.
One of the primary reasons for the increasing prevalence of CVDs in
Malaysia is the growing incidence of risk factors such as hypertension,
diabetes, and obesity. According to the National Health and Morbidity Survey
(NHMS) in 2019, 21.6% of Malaysians aged 18 years and above had hypertension,
and 6.1% had diabetes mellitus. Both these conditions are significant risk
factors for CVDs, including coronary artery disease, heart failure, and stroke.
Additionally, an unhealthy diet, lack of physical activity, and smoking have
also contributed to the rising prevalence of CVDs in Malaysia.
Another factor contributing to the increasing prevalence of CVDs in
Malaysia is the aging population. As the population ages, the risk of
developing CVDs increases. According to the World Population Prospects
report by the United Nations, the proportion of Malaysia's population aged 65
and above is expected to increase from 5.2% in 2020 to 15.2% in 2050. This
demographic shift is expected to result in a higher incidence of CVDs, which
will place greater pressure on the healthcare system in Malaysia.
Furthermore, the urbanization and economic development have also
contributed to the increasing prevalence of CVDs in Malaysia. As people move
from rural areas to urban centers, they tend to adopt more sedentary lifestyles
and unhealthy diets, which increases the risk of developing CVDs. Additionally,
economic development has led to increased availability and consumption of
processed foods, which are high in salt, sugar, and fat, and contribute to the
development of CVDs.
Download Free Sample Report
Government's
Efforts to Improve Healthcare Infrastructure and Services in Malaysia
The
government of Malaysia has made significant efforts in recent years to improve
the country's healthcare infrastructure and services.
One
of the key initiatives undertaken by the government is the construction of new
hospitals and healthcare facilities. The government has invested in building
new hospitals in areas where there is a shortage of healthcare facilities. This
has helped to improve access to healthcare for people living in rural and
remote areas. Additionally, the government has established new healthcare
centers and clinics, which have increased the availability of primary
healthcare services.
These
efforts are aimed at improving access to quality healthcare for all citizens
and ensuring that the healthcare system can meet the growing demand for
services.
Another
important initiative is the implementation of a national health insurance
scheme, known as the MySalam scheme. The scheme is designed to provide
financial assistance to low-income families and individuals who require
treatment for critical illnesses, including cancer, heart disease, and kidney
failure. The scheme is administered by the government and funded through a combination
of government contributions and contributions from participating insurance
companies.
The
government has also invested in medical technology and equipment to improve the
quality of healthcare services. This includes the purchase of advanced medical
equipment, such as magnetic resonance imaging (MRI) machines, positron emission
tomography (PET) scanners, and robotic surgery systems. Additionally, the
government has established centers of excellence in various medical
specialties, such as cardiology, neurology, and oncology, to ensure that
patients receive the highest quality of care.
Another
important aspect of the government's efforts to improve healthcare
infrastructure and services is the training and education of healthcare
professionals. The government has invested in the education and training of
healthcare professionals, including doctors, nurses, and allied health
professionals. This has helped to improve the quality of healthcare services
and ensure that patients receive the best possible care.
Finally,
the government has implemented policies to encourage the adoption of technology
in healthcare delivery. This includes the development of electronic medical
records (EMRs), which enable healthcare professionals to access patient information
quickly and easily. The government has also encouraged the use of telemedicine,
which allows patients to receive healthcare services remotely, reducing the
need for in-person consultations.
Advancements
in Technology
The
cardiovascular devices market in Malaysia has been growing rapidly in recent
years, driven in part by advancements in technology. These advancements have
enabled the development of more innovative and effective devices for the
prevention, diagnosis, and treatment of cardiovascular diseases (CVDs). Some of
the key advancements in technology that are driving the growth of the Malaysia
cardiovascular devices market are:
- Minimally
invasive procedures- Advancements in technology have enabled
the development of minimally invasive procedures for the treatment of CVDs.
These procedures involve the use of smaller incisions, which reduce the risk of
complications, decrease recovery time, and improve patient outcomes. Examples
of minimally invasive procedures include percutaneous coronary intervention
(PCI), transcatheter aortic valve replacement (TAVR), and transcatheter mitral
valve repair (TMVR).
- Implantable
devices- Implantable devices have also become more advanced,
offering new treatment options for patients with CVDs. These devices include
pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac
resynchronization therapy (CRT) devices. Newer versions of these devices
incorporate advanced features, such as remote monitoring and artificial
intelligence, to improve patient outcomes.
- 3D
printing- 3D printing technology is being used to create
custom-made cardiovascular devices, such as stents, valves, and pacemakers.
These devices can be designed to fit the unique anatomy of each patient,
improving the effectiveness of treatment, and reducing the risk of
complications.
The
advancements in technology are driving the growth of the Malaysia cardiovascular
devices market by improving patient outcomes, reducing recovery time, and
offering new treatment options for patients with CVDs. These advancements have
also increased the demand for cardiovascular devices, creating new
opportunities for manufacturers and distributors in the market.
Market
Segmentation
Malaysia cardiovascular devices market
can be segmented by type, application, end user, source, company, and region. Based on
type, the market can be divided into diagnostic & monitoring devices and
surgical devices. Based on application, the market can be segmented into
coronary artery disease, cardiac arrhythmia, heart failure, and others. Based
on end user, the market can be fragmented into hospitals & clinics,
diagnostic centers, and others. Based on source, the market can be split into
import and domestic.
Market Players
B. Braun Medical Supplies Sdn Bhd,
Abbott Medical Malaysia Sdn Bhd, LivaNova Malaysia SDN BHD, Edwards
Lifesciences (M) Sdn Bhd, GE Healthcare Sdn Bhd, BIOTRONIK Medical Devices
(Malaysia) SDN BHD, and Terumo Malaysia Sdn. Bhd. are some of the leading
players operating in the Malaysia cardiovascular devices market.
|
Attribute
|
Details
|
|
Base
Year
|
2022
|
|
Historic
Data
|
2018 – 2021
|
|
Estimated
Year
|
2023
|
|
Forecast
Period
|
2024 – 2028
|
|
Quantitative
Units
|
Revenue in USD Million, Volume in Million Units, and CAGR for 2018-2022
and 2023-2028
|
|
Report
Coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments
Covered
|
Type
Application
End User
Source
|
|
Regional
Scope
|
West
and East
|
|
Key
Companies Profiled
|
B. Braun Medical Supplies Sdn Bhd, Abbott Medical
Malaysia Sdn Bhd, LivaNova Malaysia SDN BHD, Edwards Lifesciences (M) Sdn
Bhd, GE Healthcare Sdn Bhd, BIOTRONIK Medical Devices (Malaysia) SDN BHD, and
Terumo Malaysia Sdn. Bhd.
|
|
Customization
Scope
|
10%
free report customization with purchase. Addition or alteration to country, and
regional & segment scope.
|
|
Pricing
and Purchase Options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery
Format
|
PDF and Excel through Email (We can also provide the editable
version of the report in PPT/Word format on special request)
|
Report Scope:
In this report, Malaysia cardiovascular devices market has been
segmented into following categories, in addition to the industry trends which
have also been detailed below:
·
Malaysia Cardiovascular Devices Market, By Type:
o Diagnostic & Monitoring
Devices
o Surgical Devices
·
Malaysia Cardiovascular Devices Market, By Application:
o Coronary Artery Disease
o Cardiac Arrhythmia
o Heart Failure
o Others
·
Malaysia Cardiovascular Devices Market, By End User:
o Hospitals & Clinics
o Diagnostic Centers
o Others
·
Malaysia
Cardiovascular Devices Market, By Source:
o Import
o Domestic
·
Malaysia
Cardiovascular Devices Market, By Region:
o West
o East
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in the Malaysia cardiovascular devices market.
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
Malaysia cardiovascular devices market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]